REPLIMUNE GROUP INC
REPLNASDAQ🏆 #2046 by market capEarnings Nov 4US Equity
$13.65▼ $0.02 (−0.15%)
🌅 Pre-market$13.59▼ 0.44%Regular close · extended-hours price shown1h—
24h▼ 0.1%
7d▲ 15.3%
14d▲ 151.6%
30d▲ 37.3%
1y▲ 160.0%
🏦Market Cap
$1.15B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
58
Weak
📊
Analyst Ratings
Price
$13.65
Total
15
Raised
3
Lowered
4
Avg PT
$18.67
H / L
$20 / $17
| Institution | Action | Rating | Date |
|---|---|---|---|
Leerink Partners | Upgraded | Market Perform → Outperform | 2026-08-04 |
Cantor Fitzgerald | Upgraded | Neutral → Overweight | 2026-07-31 |
Wedbush | Reiterated | Neutral | 2026-07-31 |
HC Wainwright & Co. | Downgraded | Buy → Sell | 2026-04-13 |
JP Morgan | Downgraded | Neutral → Underweight | 2026-04-13 |
Jefferies | Downgraded | Buy → Hold | 2026-04-13 |
Piper Sandler | Reiterated | Overweight | 2026-02-05 |
BMO Capital | Upgraded | Underperform → Market Perform | 2025-11-03 |
Barclays | Downgraded | Overweight → Equal Weight | 2025-07-23 |
EF Hutton | Reiterated | Buy | 2023-06-07 |
SVB Leerink | Reiterated | Outperform | 2022-12-07 |
BTIG | Reiterated | Buy | 2020-11-17 |
H.C. Wainwright | Reiterated | Buy | 2020-01-21 |
Roth Capital | Reiterated | Buy | 2019-09-04 |
Chardan Capital | Reiterated | Buy | 2019-07-23 |
One row per institution, most recent rating